In the high-stakes world of drug discovery, building a new medicine is a lot like microscopic architecture. To create the next breakthrough antibiotic or brain-targeting therapy, chemists must snap together fragile molecular building blocks. But for decades, one of the most useful chemical pieces has been notoriously stubborn, requiring conditions so harsh they often destroy the very medicine being built. Now, researchers have found a way to pick the lock.
A team has uncovered how a common bacterial pathogen uses a single protein to quietly undermine the human immune system, by both shutting down key warning signals and blocking the cell’s ability to restore them. Published in Advanced Science, the study reveals a surprisingly precise, two-pronged strategy that helps bacteria gain the upper hand during infection, and points toward new ways of thinking about treatment in an era of rising antibiotic resistance.
